EICHOR
● Not Yet Recruiting
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Condition: Overweight · Obesity · Sponsor: Novo Nordisk A/S
About this study
The purpose of this clinical study is to look at how well a study medicine called cagrilintide helps people living with excess body weight to lose weight. Participants will either get cagrilintide, the active study medicine being tested or placebo, a medicine that has no active medicine in it. Which treatment participants get is decided by chance. Cagrilintide is a new medicine under development that doctors cannot prescribe yet, but it has been tested in humans before. Participants will be in this clinical study for about 9 months.
This description comes directly from the study's public registry record.
Talk to the study team
Novo Nordisk · (+1) 866-867-7178 · clinicaltrials@novonordisk.com
Always discuss trial participation with your own doctor first.
Locations (36)
| Hope Clin Res & Wellness | Conyers, Georgia, United States | — |
| East West Med Res Inst | Honolulu, Hawaii, United States | — |
| Walgreens - Store 11760 | Oak Park, Illinois, United States | — |
| Midwest Inst For Clin Res | Indianapolis, Indiana, United States | — |
| The Alliance for Multispecialty Research LLC AMR | Lexington, Kentucky, United States | — |
| PharmQuest | Greensboro, North Carolina, United States | — |
| KDCILM, LLC & Accellacare US, Inc. | Wilmington, North Carolina, United States | — |
| Coastal Carolina Res Ctr | North Charleston, South Carolina, United States | — |
| Health Res of Hampton Roads | Newport News, Virginia, United States | — |
| National Clin Res Inc. | Richmond, Virginia, United States | — |
| Selma Medical Associates | Winchester, Virginia, United States | — |
| General Hospital Of Athens Alexandra - Department of Endocrinology, Diabetes Center | Athens, Greece | — |
+ 24 more locations — full list on the registry record.
Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07745504